Robert B. Bazemore, President & CEO at Epizyme, Inc. (EPZM), sold 3,890 shares at $11.21 ($44K) on 2021-02-04, disclosed to the SEC on 2021-02-05.
Scheduled sale ($44k) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| EPZM | SELL | 2021-01-27 | $138K | — | Filing → |
| EPZM | SELL | 2020-06-30 | $154K | — | Filing → |
| EPZM | SELL | 2020-06-22 | $220K | — | Filing → |